3.
贫血对NSCLC患者化疗疗效的影响
The impact of anemia on chemotherapy efficacy of NSCLC patients
| Influencing factors | n | OR | χ2 | P |
| OR: objective response. | ||||
| Pre-chemotherapy | 12.219 | < 0.001 | ||
| Anemia | 74 | 24.3% (18/74) | ||
| Normal | 66 | 53.0% (35/66) | ||
| Post-chemotherapy | 11.671 | 0.001 | ||
| Anemia | 100 | 29.0% (29/100) | ||
| Normal | 40 | 60.0% (24/40) | ||